Article
Protecting Innovation In A Borderless Pharma Economy: The Reality Of Globalized Pharma Innovation
Today’s drug development programs routinely span continents: distributed research teams, multinational clinical trial networks, and complex webs of cross-border licensing, contract manufacturing...
Marshall, Gerstein & Borun LLP